摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-(3-aza-pentanediyl)-bis-carbamic acid diethyl ester | 99864-17-2

中文名称
——
中文别名
——
英文名称
N,N'-(3-aza-pentanediyl)-bis-carbamic acid diethyl ester
英文别名
N,N'-(3-Aza-pentandiyl)-bis-carbamidsaeure-diaethylester;ethyl N-[2-[2-(ethoxycarbonylamino)ethylamino]ethyl]carbamate
<i>N</i>,<i>N</i>'-(3-aza-pentanediyl)-bis-carbamic acid diethyl ester化学式
CAS
99864-17-2
化学式
C10H21N3O4
mdl
——
分子量
247.294
InChiKey
UCJYRTFIJFSOEJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    17
  • 可旋转键数:
    10
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    88.7
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
    申请人:Government of the USA, the Secretary Department of Health and Human Services
    公开号:US20030147845A1
    公开(公告)日:2003-08-07
    Diazeniumdiolates, wherein the N 1 position is substituted by an inorganic or organic moiety and the O 2 -oxygen is bound to a substituted or unsubstituted aromatic group, are provided. Also provided are O 2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates (O 2 -glycosylated diazeniumdiolates) and O 2 -substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates (1-[(2-carboxylato)pyrrolidin-1-yl]diazeniumdiolates). The O 2 -aryl diazeniumdiolates are stable with respect to the hydrolytic generation of nitric oxide in neutral to acidic solutions and generate nitric oxide in basic or nucleophilic environments or microenvironments. Also provided are compositions, including pharmaceutical compositions, comprising such compounds and methods of using such compounds.
    本发明提供了N1位置被无机或有机基团取代,且O2氧原子与取代或未取代芳香基团结合的二氧化氮酸酯。还提供了O2-糖基化的1-取代二氮-1-ium-1,2-二醇酸酯(O2-糖基化的二氮酸酯)和O2-取代的1-[(2-羧基)吡咯烷-1-基]二氮-1-ium-1,2-二醇酸酯(1-[(2-羧基)吡咯烷-1-基]二氮酸酯)。O2-芳基二氮酸酯在中性至酸性溶液中对解产生的一氧化氮稳定,而在碱性或亲核环境或微环境中产生一氧化氮。还提供了包括制药组合物在内的此类化合物的组合物和使用此类化合物的方法。
  • O2-Arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates
    申请人:The United States Government Office of Technoloy Transfer
    公开号:EP1439187A1
    公开(公告)日:2004-07-21
    Diazeniumdiolates, wherein the N1 position is substituted by an inorganic or organic moiety and the O2-oxygen is bound to a substituted or unsubstituted aromatic group, are provided. Also provided are O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates (O2-glycosylated diazeniumdiolates) and O2-substituted 1-[(2-carboxylato)pyrrolidin-1-y]diazen-1-ium-1,2-diolates (1-[(2-carboxylato)öyrrolidin-1-yl]diazeniumdiolates). The O2-aryl diazeniumdiolates are stable with respect to the hydrolytic generation of nitric oxide in neutral to acidic solutions and generate nitric oxide in basic or nucleophilic environments or microenvironments. Also provided are compositions, including pharmaceutical compositions, comprising such compounds and methods of using such compounds.
    提供了 N1 位被无机或有机分子取代且 O2-氧与取代或未取代的芳香基团结合的重氮鎓二元醇盐。还提供了 O2-糖基化的 1-取代二氮-1-鎓-1,2-二元醇盐(O2-糖基化二氮二元醇盐)和 O2-取代的 1-[(2-羧基)吡咯烷-1-y]二氮-1-鎓-1,2-二元醇盐(1-[(2-羧基)öyrrolidin-1-yl]二氮二元醇盐)。在中性至酸性溶液中,O2-芳基重氮二元醇盐在解生成一氧化氮方面是稳定的,在碱性或亲核性环境或微环境中生成一氧化氮。此外,还提供了包含此类化合物的组合物(包括药物组合物)和使用此类化合物的方法。
  • O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates
    申请人:The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services
    公开号:EP2292630A1
    公开(公告)日:2011-03-09
    O2-Substituted 1-[(2-carboxylato)pyrrolidin-1-yl] diazeniumdiolates are stable in aqueous solution and, in many cases, they can be activated for NO release by enzymatic action. Furthermore, if an N-nitroso derivative is formed by net formal cleavage of the N-N double bond of the 1-[(2-carboxylato)pyrrolin-1-yl]diazen-1-ium-1,2-diolate, the N-nitroso compound is noncarcinogenic. Such compounds are believed to be particularly useful in the treatment of fulminant liver failure, malaria, respiratory problems, impotence, and a variety of cardiovascular/hematologic disorders.
    O2 取代的 1-[(2-羧基)吡咯烷-1-基]二氮杂环戊烷溶液中是稳定的,在许多情况下,它们可以通过酶的作用被激活以释放 NO。此外,如果 1-[(2-carboxylato)pyrrolin-1-yl]diazen-1-ium-1,2-diolate(1-[(2-羧基)吡咯烷-1-基]重氮-1,2-二酸酯)的 N-N 双键发生净形式裂解而形成 N-亚硝基衍生物,则该 N-亚硝基化合物不会致癌。此类化合物被认为特别适用于治疗暴发性肝衰竭、疟疾、呼吸系统疾病、阳痿以及各种心血管/血液疾病。
  • O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
    申请人:Saavedra E. Joseph
    公开号:US20050214249A1
    公开(公告)日:2005-09-29
    Diazeniumdiolates, wherein the N 1 position is substituted by an inorganic or organic moiety and the O 2 -oxygen is bound to a substituted or unsubstituted aromatic group, are provided. Also provided are O 2 -glycosylated 1-substituted diazen- 1 -ium-1,2-diolates (O 2 -glycosylated diazeniumdiolates) and O 2 -substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates (1-[(2-carboxylato)pyrrolidin-1-yl]diazeniumdiolates). The O 2 -aryl diazeniumdiolates are stable with respect to the hydrolytic generation of nitric oxide in neutral to acidic solutions and generate nitric oxide in basic or nucleophilic environments or microenvironments. Also provided are compositions, including pharmaceutical compositions, comprising such compounds and methods of using such compounds.
    重氮二醇,其中 N 1 位被无机或有机分子取代,而 O 2 -氧与取代或未取代的芳香基团结合。还提供 O 2 -糖基化的 1-取代的重氮-1-基团。 1 -鎓-1,2-二醇(O 2 -糖基化的重氮二醇)和 O 2 -取代的 1-[(2-羧基)吡咯烷-1-基]重氮-1,2-鎓二元醇盐(1-[(2-羧基)吡咯烷-1-基]重氮鎓二元醇盐)。O 2 -芳基二氮杂环戊烷在中性至酸性溶液中对一氧化氮解生成稳定,在碱性或亲核性环境或微环境中生成一氧化氮。此外,还提供了包含此类化合物的组合物(包括药物组合物)和使用此类化合物的方法。
  • O?2 -ARYLATED OR O?2 -GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O?2 -SUBSTITUTED 1- (2-CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM-1,2-DIOLATES
    申请人:THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    公开号:EP0929538B1
    公开(公告)日:2004-11-24
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸